Ulcerative Colitis Clinical Trials in Morristown, New Jersey

4 studies are recruiting for ulcerative colitis in Morristown, New Jersey right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis

    Ulcerative colitis (UC) is a type of inflammatory bowel disease that causes inflammation and bleeding from the lining of the rectum and colon (large intestine). This study will assess how Risankizumab moves through the body as well as how safe and effective it is in treating pediatric participants …

    Stage
    Phase 3
    Ages
    2 to 17
    Site
    Goryeb Children's Hospital /ID# 271801, Morristown, New Jersey
    Locations
    64 in total
    Run by
    AbbVie

    See if you can join NCT07071519 on ClinicalTrials.gov

  2. A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease

    The main aim of this study is to learn how the body of a child or teenager with moderately to severely active ulcerative colitis (UC) or Crohn's disease (CD) processes vedolizumab (pharmacokinetics) given just under the skin subcutaneously (SC). The participants will be treated with vedolizumab for…

    Stage
    Phase 3
    Ages
    2 to 17
    Site
    Atlantic Health System, Morristown, New Jersey
    Locations
    54 in total
    Run by
    Takeda

    See if you can join NCT06100289 on ClinicalTrials.gov

  3. A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)

    The main aim of this study is to learn about medical problems (adverse events) if vedolizumab subcutaneously (SC) is given to a child or teenager with UC or CD for a long time. Other aims are to understand if the long time use of vedolizumab SC has an impact on the time period until hospital visits…

    Stage
    Phase 3
    Ages
    2 to 17
    Site
    Atlantic Health - Morristown Medical Center, Morristown, New Jersey
    Locations
    54 in total
    Run by
    Takeda

    See if you can join NCT06405087 on ClinicalTrials.gov

  4. A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)

    The study is an extension of two parent studies (MLN0002-3024 [NCT04779307] and MLN0002-3025 [NCT04779320]). Participants must have participated in one of the previous studies. The purpose of this study is to collect the long-term safety of vedolizumab in children with UC or CD.

    Stage
    Phase 3
    Ages
    2 and older
    Site
    Goryeb Children's Hospital, Morristown, New Jersey
    Locations
    98 in total
    Run by
    Takeda

    See if you can join NCT05442567 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.